A small molecule in a peptide catalogue
5-Amino-1MQ is a quinolinium compound: a small organic molecule, not a chain of amino acids. It sits in this catalogue because it appears in metabolic research alongside compounds that are peptides, not because it shares their chemistry.
That distinction has practical consequences. Small molecules behave differently in storage, in solution and in how they are handled, and assuming peptide guidance applies to them is a mistake.
Inhibiting an enzyme, not activating a receptor
Almost every other compound in this catalogue works by engaging a receptor. 5-Amino-1MQ does the opposite kind of thing: it is studied as an inhibitor of nicotinamide N-methyltransferase, an enzyme involved in how cells handle nicotinamide.
That enzyme sits near the NAD+ salvage pathway, which is why the compound turns up in the same conversations as the coenzyme research. Whether inhibiting it produces anything useful is exactly what the studies are examining.
| Type | Small molecule, not a peptide |
| Class | Quinolinium compound |
| Proposed target | NNMT, an enzyme |
| Mechanism type | Inhibition rather than activation |
| Format | Pre-filled research pen |
| Purity | ≥ 99% (HPLC) |
| Evidence base | Cell models and animal work |
| Category | Research use only |
Facts about the substance itself, none of which extend to effects.
Where the evidence currently sits
The work is largely in cell models and animals, examining metabolic markers and adipocyte behaviour. It is a young field and the compound has not been through the kind of development programme that would produce human data.
Read alongside the online summaries, the studies are considerably more cautious. That gap is a recurring feature of newer compounds and it is worth checking for.
5-Amino-1MQ in the catalogue
Purity verified by HPLC at 99% and above; the batch document is yours on request.
Where this fits in
The three pages that sit closest to this one.
About 5-Amino-1MQ
Four things worth knowing before you buy.